Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.69 |
| ▸ | EP300 | Q09472 | 2/20 | 0.69 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.69 |
| ▸ | SOX18 | P35713 | 1/20 | 0.67 |
| ▸ | BID | P55957 | 7/20 | 0.65 |
| ▸ | MCL1 | Q07820 | 7/20 | 0.65 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.65 |
| ▸ | BAK1 | Q16611 | 6/20 | 0.65 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.56 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.56 |
| ▸ | SGMS1 | Q86VZ5 | 2/20 | 0.53 |
| ▸ | SGMS2 | Q8NHU3 | 2/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21530605 | 0.90 | BID (0.79) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL20771694 | 0.82 | KAT8 (1.00) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL12249375 | 0.82 | SOX18 (0.57) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL20333017 | 0.80 | SOX18 (1.00) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL20781123 | 0.79 | KAT8 (0.60) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL22331059 | 0.79 | KAT8 (0.60) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL29919590 | 0.78 | BID (0.67) | KAT8EP300KAT5BIDMCL1 | |
| SCHEMBL3954149 | 0.78 | BID (0.67) | KAT8EP300KAT5BIDMCL1 | |
| SCHEMBL16870672 | 0.77 | BID (0.61) | KAT8EP300KAT5SOX18BID | |
| SCHEMBL11868931 | 0.77 | BID (0.61) | KAT8EP300KAT5SOX18BID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220273585-A1 | Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture | TILMAN (BE) | 2022-09-01 | — | — | US | claimed |
| EP-4049654-A1 | COMPOSITION COMPRISING AT LEAST ONE NATURAL OR SYNTHETIC CANNABINOID WITHOUT EUPHORIC EFFECT AND MANUFACTURING METHOD THEREOF | Eleonor (BE) | 2022-08-31 | — | — | EP | claimed |
| EP-1311258-B1 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INC (US) | 2005-04-06 | — | — | EP | claimed |
| EP-1311258-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | Insmed Incorporated (US) | 2003-05-21 | — | — | EP | claimed |
| US-6541522-B2 | Including longistyline A-2-carboxylic acid as a dietary supplement | INSMED INCORPORATED | 2003-04-01 | — | — | US | claimed |
| US-20020058708-A1 | Compositions containing hypotriglyceridemically active stilbenoids | SHAMAN PHARMACEUTICALS | 2002-05-16 | — | — | US | claimed |
| US-20020055541-A1 | Compositions containing hypotriglyceridemically active stilbenoids | SHAMAN PHARMACEUTICALS, INC. | 2002-05-09 | — | — | US | claimed |
| WO-2002013809-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | claimed |
| WO-2002013806-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | claimed |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2026-01-15 | — | — | US | disclosed |
| US-12458049-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250160327-A1 | USE OF CHROMENE OR CHROMANE DERIVATIVES AS HERBICIDAL AGENTS | ECOLE POLYTECHNIQUE (FR) | 2025-05-22 | — | — | US | disclosed |
| EP-3952651-B1 | USE OF BENZOXEPINE DERIVATIVES AS HERBICIDES | ECOLE POLYTECH (FR) | 2025-04-23 | — | — | EP | disclosed |
| US-12193443-B2 | Use of benzoxepin derivatives as a herbicide | ECOLE POLYTECHNIQUE (FR) | 2025-01-14 | — | — | US | disclosed |
| US-20020055541-A1 | Compositions containing hypotriglyceridemically active stilbenoids | SHAMAN PHARMACEUTICALS, INC. | 2002-05-09 | — | — | US | disclosed |
| WO-2002013809-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2002013806-A2 | COMPOSITIONS CONTAINING HYPOTRIGLYCERIDEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2001074753-A1 | SYNTHETIC DERIVATIVES OF LUNULARIC ACID, MEDICAMENTS CONTAINING SAID COMPOUNDS, METHOD FOR PRODUCING THE LUNULARIC ACID DERIVATIVES AND THE USE THEREOF | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074753-A1 | SYNTHETIC DERIVATIVES OF LUNULARIC ACID, MEDICAMENTS CONTAINING SAID COMPOUNDS, METHOD FOR PRODUCING THE LUNULARIC ACID DERIVATIVES AND THE USE THEREOF | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2001-10-11 | — | — | WO | disclosed |
| WO-1988000968-A2 | PROCESS FOR INDUCING SECONDARY METABOLITE PRODUCTION IN PLANT CULTURES AND MEANS THEREOF | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058708-A1 | Compositions containing hypotriglyceridemically active stilbenoids | CPT1B, CPT1A, LIPC | KAT8 3259/4885EP300 1329/4885KAT5 2043/4885 |
| US-20220273585-A1 | Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture | CNR2, CNR1, FAAH | KAT8 4854/4885EP300 4466/4885KAT5 4674/4885 |
| US-12458049-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | KAT8 2863/4885EP300 2581/4885KAT5 4310/4885 |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | TAS2R7, TAS2R31, TAS2R40 | KAT8 3626/4885EP300 2689/4885KAT5 4812/4885 |
| US-20250160327-A1 | USE OF CHROMENE OR CHROMANE DERIVATIVES AS HERBICIDAL AGENTS | CBX8, CBX3, CDYL | KAT8 739/4885EP300 4646/4885KAT5 2502/4885 |
| US-20020055541-A1 | Compositions containing hypotriglyceridemically active stilbenoids | CPT1B, CPT1A, LIPC | KAT8 3259/4885EP300 1329/4885KAT5 2043/4885 |
| US-12193443-B2 | Use of benzoxepin derivatives as a herbicide | BROX, CYP4X1, DDT | KAT8 4631/4885EP300 4641/4885KAT5 3012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.